Abstract:Cellular responses to ionizing radiation (IR) include (a) activation of signal transduction enzymes; (b) stimulation of DNA repair, most notably DNA double strand break (DSB) repair by homologous or nonhomologous recombinatorial pathways; (c) activation of transcription factors and subsequent IR-inducible transcript and protein changes; (d) cell cycle checkpoint delays in G1, S, and G2 required for repair or for programmed cell death of severely damaged cells; (e) activation of zymogens needed for programmed cell death (although IR is a poor inducer of such responses in epithelial cells); and (f) stimulation of IR-inducible proteins that may mediate bystander effects influencing signal transduction, DNA repair, angiogenesis, the immune response, late responses to IR, and possibly adaptive survival responses. The overall response to IR depends on the cell's inherent genetic background, as well as its ability to biochemically and genetically respond to IR-induced damage. To improve the anti-tumor efficacy of IR, our knowledge of these pleiotropic responses must improve. The most important process for the survival of a tumor cell following IR is the repair of DNA double strand breaks (DSBs). Using yeast two-hybrid analyses along with other molecular and cellular biology techniques, we cloned transcripts/proteins that are involved in, or presumably affect, nonhomologous DNA double strand break end-joining (NHEJ) repair mediated by the DNA-PK complex. Using Ku70 as bait, we isolated a number of Ku-binding proteins (KUBs). We identified the first X-ray-inducible transcript/protein (xip8, Clusterin (CLU)) that associates with DNA-PK. A nuclear form of CLU (nCLU) prevented DNA-PK-mediated end joining, and stimulated cell death in response to IR or when overexpressed in the absence of IR. Structure-function analyses using molecular and cellular (including green fluorescence-tagged protein trafficking) biology techniques showed that nCLU appears to be an inactive protein residing in the cytoplasm of epithelial cells. Following IR injury, nCLU levels increase and an as yet undefined posttranslational modification appears to alter the protein, exposing nuclear localization sequences (NLSs) and coiled-coil domains. The modified protein translocates to the nucleus and triggers cell death, presumably through its interaction specifically with Ku70. Understanding nCLU responses, as well as the functions of the KUBs, will be important for understanding DSB repair. Knowledge of DSB repair may be used to improve the antitumor efficacy of IR, as well as other chemotherapeutic agents.

Karyoptosis as a novel type of UVB-induced regulated cell death

Dysregulated CREB3 cleavage at the nuclear membrane induces karyoptosis-mediated cell death

Targeting cell death pathways for cancer therapy: recent developments in necroptosis, pyroptosis, ferroptosis, and cuproptosis research

The molecular machinery of regulated cell death

Melanoma biology and treatment: a review of novel regulated cell death-based approaches

In my end is my beginning: control of end resection and DSBR pathway ‘choice’ by cyclin-dependent kinases

The ribotoxic stress response drives UV-mediated cell death

Regulated cell death (RCD) in cancer: key pathways and targeted therapies

UVA induces retinal photoreceptor cell death via receptor interacting protein 3 kinase mediated necroptosis

Targeting regulated cell death in tumor nanomedicines

Regulated Cell Death in Urinary Malignancies

MLKL, a new actor of UVB-induced apoptosis in human diploid dermal fibroblasts

When X-ray-inducible Proteins Meet DNA Double Strand Break Repair

CTSB Nuclear Translocation Facilitates DNA Damage and Lysosomal Stress to Promote Retinoblastoma Cell Death

Cuproptosis, ferroptosis and PANoptosis in tumor immune microenvironment remodeling and immunotherapy: culprits or new hope

The scheme, and regulative mechanism of pyroptosis, ferroptosis, and necroptosis in radiation injury

Regulated cell death pathways and their roles in homeostasis, infection, inflammation, and tumorigenesis

Activated aggregation‐induced emission therapeutics agents for triggering regulated cell death

Phosphorylation-triggered CUEDC2 Degradation Promotes UV-induced G1 Arrest Through APC/C(Cdh1) Regulation.

Regulated cell death: discovery, features and implications for neurodegenerative diseases

Therapeutic strategies of targeting non-apoptotic regulated cell death (RCD) with small-molecule compounds in cancer